The autoimmune response induced by mouse hepatitis virus A59 is expanded by a hepatotoxic agent

International Immunopharmacology

Volumn 9, Issue 5, 2009, Pages 627-631

  Aparicio, José L ^a   Duhalde Vega, Maite ^a   Loureiro, María E ^a   Retegui, Lilia A ^a  

^a Instituto de Quimica y Fisicoquimica Biologicas Buenos Aires   (Argentina)

Author keywords

Autoimmune hepatitis; Autoimmune response; Fumarylacetoacetate hydrolase; Mouse hepatitis virus

Indexed keywords

ADJUVANT; AUTOANTIBODY; FUMARYLACETOACETASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; CARBON TETRACHLORIDE; HYDROLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LIVER INJURY; LIVER TOXICITY; MOUSE; MOUSE HEPATITIS VIRUS A59; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS INFECTION; ANIMAL; ANIMAL HEPATITIS; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; COMPLICATION; DRUG EFFECTS; HEPATITIS, AUTOIMMUNE; IMMUNOLOGY; KIDNEY; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TOXICITY; VIROLOGY;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; CARBON TETRACHLORIDE; FEMALE; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, ANIMAL; HYDROLASES; KIDNEY; LIVER; MICE; MICE, INBRED BALB C; MURINE HEPATITIS VIRUS; ORGAN SPECIFICITY;

EID: 63549096901     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.02.006     Document Type: Article

References (34)

1. Cohen A.D., and Shoenfeld Y. The viral-autoimmunity relationship. Viral Immunol 8 (1995) 1-9
2. Lawson C.M. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci 57 (2000) 552-560
3. Kohm A.P., Fuller K.G., and Miller S.D. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. TRENDS Microbiol 11 (2003) 101-105
4. Fujinami R.S., von Herrath M.G., Christen U., and Whitton J.L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microb Rev 19 (2006) 80-94
5. Coutelier J.-P., Coulie P.G., Wauters P., Heremans H., and van der Logt J.T.M. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J Virol 64 (1990) 5383-5388
6. Rose N.R. The role of infection in the pathogenesis of autoimmune disease. Semin Immunol 10 (1998) 5-13
7. Godfraind C., and Coutelier J.-P. Morphological analysis of mouse hepatitis virus A59-induced pathology with regard to viral receptor expression. Histol Histopathol 13 (1998) 181-199
8. Lardans V., Godfraind C., van der Logt J.T.M., Heessen F.W.A., Gonzalez M.D., and Coutelier J.P. Polyclonal B lymphocyte activation induced by mouse hepatitis virus A59 infection. J Gen Virol 77 (1996) 1005-1009
9. Mathieu P.A., Gómez K.A., Coutelier J.P., and Retegui L.A. Identification of two liver proteins recognized by autoantibodies elicited in mice infected with mouse hepatitis virus A59. Eur J Immunol 31 (2001) 1447-1455
10. Farris A.D., Keech C.L., Gordon T.P., and McCluskey J. Epitope mimics and determinant spreading: pathways to autoimmunity. Cell Mol Life Sci 57 (2000) 569-578
11. Croxford J.L., Olson J., and Miller S.D. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus induced demyelinating disease model of multiple sclerosis. Autoimmun Rev 1 (2000) 251-260
12. Liang B., and Mamula M.J. Molecular mimicry and the role of B lymphocytes in the processing of autoantigens. CMLS, Cell Mol Life Sci 57 (2000) 561-568
13. Duhalde-Vega M., Loureiro M.E., Mathieu P.A., and Retegui L.A. The peptide specificities of the autoantibodies elicited by mouse hepatitis virus A59. J Autoimmun 27 (2006) 203-209
14. Matzinger P. The Danger model: a renewed sense of self. Science 296 (2002) 301-305
15. Christen U., Holdener M., and Hintermann E. Animal models for autoimmune hepatitis. Autoimmun Rev 6 (2007) 306-311
16. Smith C.I., Cooksley W.G.E., and Powell L.W. Cell-mediated immunity to liver antigens in toxic liver injury. I. Occurrence and specificity. Clin Expl Immunol 39 (1980) 607-617
17. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurements with the folin phenol reagent. J Biol Chem 193 (1951) 265-275
18. Mathieu P.A., Gómez K.A., Coutelier J.P., and Retegui L.A. Sequence similarity and structural homologies are involved in the autoimmune response elicited by mouse hepatitis virus A59. J Autoimmun 23 (2004) 117-126
19. Plotz P.H. The autoantibody repertoire: searching for order. Nat Rev Immunol 3 (2003) 73-78
20. Kono H., and Rock K.L. How dying cells alert the immune system to danger. Nat Rev Immunol 8 (2008) 279-289
21. Coutelier J.P., Coulie P.G., Wauters P., Heremans H., and van der Logt J.T.M. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J Virol 64 (1990) 5383-5388
22. Godfraind C., Havaux N., Holmes K.V., and Coutelier J.-P. Role of virus receptor-bearing endothelial cells of the blood-brain barrier in preventing the spread of mouse hepatitis virus-A59 into the central nervous system. J Neurovirology 3 (1997) 428-434
23. Louis H., Van Laethem J.-L., Wu W., Quertinmont E., Degraef C., Van den Berg K., et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 28 (1998) 1607-1615
24. Mori Y., Mori T., Yoshida H., Ueda S., Iesato K., Wakashin Y., et al. Study of cellular immunity in experimental autoimmune hepatitis in mice. Clin Exp Immunol 57 (1984) 85-92
25. Lapierre P., Djilali-Saiah I., Vitozzi S., and Alvarez F. A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens. Hepatology 39 (2004) 1066-1074
26. Voehringer D., Blaser C., Grawitz A.B., Chisari F.V., Buerki K., and Pircher H. Break of T cell ignorance to a viral antigen in the liver induces hepatitis. J Immunol 165 (2000) 2415-2422
27. Holdener M., Hintermann E., Bayer M., Rhode A., Rodrigo E., Intereder G., et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 205 (2008) 1409-1422
28. Czaja A.J. Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol 96 (2001) 1224-1231
29. Lang K.S., Georgiev P., Recher M., Navarini A.A., Bergthaler A., Heikenwalder M., et al. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest 116 (2006) 2456-2463
30. Longhi M.S., Hussain M.J., Mitry R.R., Arora F.K., Mieli-Vergani G., Vergani D., et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 176 (2006) 4484-4491
31. Lüth S., Huber S., Schramm C., Buch T., Zander S., Stadelmannet C., et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 118 (2008) 3403-3410
32. Behrens M.D., Wagner W.M., Krco C.J., Erskine C.L., Kalli K.R., Krempski J., et al. The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity. Blood 111 (2008) 1472-1479
33. Liu G., and Zhao Y. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+CD25+ T cells. Immunology 122 (2007) 149-156
34. Marshak-Rothstein A., and Rifkin I.R. Immunologically active autoantigens: the role of Toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 25 (2007) 419-441